Berberis libanotica

Ethnobotanical Studies

Shouf Biosphere Reserve, Lebanon

Uses: diabetes, liver and gallbladder disorders, jaundice (children), hepatitis, emmanagogue, headaches, cancer, inflammatory, astma, anemia, wounds, hemorrhoids, skin disorders, ulcer, dysentery, snake bites

DOI:: 10.1186/s13002-022-00568-y
PubMed:: 36572929

Studies

Comparative Study of Phytochemistry, Antioxidant and Biological Activities of Berberis libanotica Fruit and Leaf Extracts.

Immunology Phytochemistry

Dawra M et al (2023).; Plants (Basel).
DOI:: 10.3390/plants12102001
PubMed:: 37653917

Ethnobotanical survey of medicinal wild plants in the Shouf Biosphere Reserve, Lebanon.

Ethnobotany

Hani N et al (2022).; J Ethnobiol Ethnomed.
DOI:: 10.1186/s13002-022-00568-y
PubMed:: 36572929

Chemical Composition, Antioxidant and Cytotoxic Activities of Roots and Fruits of Berberis libanotica.

El Hosry L et al (2016).; Nat Prod Commun.
PubMed:: 27319140

Berberis libanotica extract targets NF-κB/COX-2, PI3K/Akt and mitochondrial/caspase signalling to induce human erythroleukemia cell apoptosis.

Immunology

Diab S et al (2015).; Int J Oncol.
DOI:: 10.3892/ijo.2015.3012
PubMed:: 25997834

Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.

Cancer

El-Merahbi R et al (2014).; PLoS One.
DOI:: 10.1371/journal.pone.0112453
PubMed:: 25380390

Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity.

Summary

Researchers evaluated the roots of Berberis aetnensis C. Presl. and Berberis libanotica Ehrenb. ex C.K. Schneid. for their potential use in treating Alzheimer's disease. They tested the roots for anticholinesterase and antioxidant properties. This is the first study to evaluate these plants for these properties. The results indicated that both plants could be useful in the treatment of AD. This study highlights the potential of natural compounds in the treatment of Alzheimer's disease.

Neuroscience

Bonesi M et al (2013).; J Pharm Pharmacol.
DOI:: 10.1111/jphp.12172
PubMed:: 24236982